STAGE IVB HEPATOCELLULAR CARCINOMA AJCC V8
Clinical trials for STAGE IVB HEPATOCELLULAR CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVB HEPATOCELLULAR CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVB HEPATOCELLULAR CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver cancer combo therapy trial halted early
Disease control TerminatedThis study tested whether combining two immunotherapy drugs, nivolumab and ipilimumab, could shrink tumors in people with advanced liver cancer that had already gotten worse after standard first-line treatment. The trial enrolled 15 adults whose cancer had spread or could not be …
Matched conditions: STAGE IVB HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated May 17, 2026 01:01 UTC
-
New hope for recurrent liver cancer after transplant?
Disease control TerminatedThis study tested the drug lenvatinib in people whose liver cancer returned after a liver transplant. The goal was to see if the drug could shrink or slow the cancer. Only 3 people took part before the study was stopped early. The drug works by blocking enzymes that help cancer c…
Matched conditions: STAGE IVB HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC